These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10908359)

  • 1. The effect of chromatin structure on cisplatin damage in intact human cells.
    Davies NP; Hardman LC; Murray V
    Nucleic Acids Res; 2000 Aug; 28(15):2954-8. PubMed ID: 10908359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The sequence specificity of the anti-tumour drug, cisplatin, in telomeric DNA sequences compared with consecutive guanine DNA sequences.
    Murray V; Kandasamy N
    Anticancer Agents Med Chem; 2012 Mar; 12(3):177-81. PubMed ID: 22044000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of chromatin structure on bleomycin-DNA interactions at base pair resolution in the human beta-globin gene cluster.
    Cairns MJ; Murray V
    Biochemistry; 1996 Jul; 35(26):8753-60. PubMed ID: 8679639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic and phylogenetic footprinting at the epsilon-globin silencer region in intact human cells.
    Temple MD; Freebody J; Murray V
    Biochim Biophys Acta; 2004 May; 1678(2-3):126-34. PubMed ID: 15157738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA damage by anti-cancer agents resolved at the nucleotide level of a single copy gene: evidence for a novel binding site for cisplatin in cells.
    Grimaldi KA; McAdam SR; Souhami RL; Hartley JA
    Nucleic Acids Res; 1994 Jun; 22(12):2311-7. PubMed ID: 8036159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein-DNA footprinting of the human epsilon-globin promoter in human intact cells using nitrogen mustard analogues and other DNA-damaging agents.
    Temple MD; Cairns MJ; Kim A; Murray V
    Biochim Biophys Acta; 1999 Jun; 1445(3):245-56. PubMed ID: 10366709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein-DNA interactions in the human beta-globin locus control region hypersensitive site-2 as revealed by four nitrogen mustards.
    Temple MD; Cairns MJ; Denny WA; Murray V
    Nucleic Acids Res; 1997 Aug; 25(16):3255-60. PubMed ID: 9241238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of DNA conformation on cisplatin adduct formation.
    Bubley GJ; Xu J; Kupiec N; Sanders D; Foss F; O'Brien M; Emi Y; Teicher BA; Patierno SR
    Biochem Pharmacol; 1996 Mar; 51(5):717-21. PubMed ID: 8615910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An investigation of the sequence-specific interaction of cis-diamminedichloroplatinum(II) and four analogues, including two acridine-tethered complexes, with DNA inside human cells.
    Murray V; Motyka H; England PR; Wickham G; Lee HH; Denny WA; McFadyen WD
    Biochemistry; 1992 Dec; 31(47):11812-7. PubMed ID: 1445914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The major chromatin protein histone H1 binds preferentially to cis-platinum-damaged DNA.
    Yaneva J; Leuba SH; van Holde K; Zlatanova J
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13448-51. PubMed ID: 9391045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction of DNA-targeted 9-aminoacridine-4-carboxamide platinum complexes with DNA in intact human cells.
    Temple MD; Recabarren P; McFadyen WD; Holmes RJ; Denny WA; Murray V
    Biochim Biophys Acta; 2002 Apr; 1574(3):223-30. PubMed ID: 11997087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA sequence selectivity of cisplatin analogues in intact human cells.
    Murray V; Whittaker J; McFadyen WD
    Chem Biol Interact; 1998 Mar; 110(1-2):27-37. PubMed ID: 9566723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin intrastrand adducts sensitize DNA to base damage by hydrated electrons.
    Behmand B; Wagner JR; Sanche L; Hunting DJ
    J Phys Chem B; 2014 May; 118(18):4803-8. PubMed ID: 24779712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NF-1C, Sp1, and Sp3 are essential for transcription of the human gene for P450c17 (steroid 17alpha-hydroxylase/17,20 lyase) in human adrenal NCI-H295A cells.
    Lin CJ; Martens JW; Miller WL
    Mol Endocrinol; 2001 Aug; 15(8):1277-93. PubMed ID: 11463853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of cisplatin and analogues with DNA in reconstituted chromatin.
    Galea AM; Murray V
    Biochim Biophys Acta; 2002 Dec; 1579(2-3):142-52. PubMed ID: 12427549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Footprinting the 'essential regulatory region' of the retinoblastoma gene promoter in intact human cells.
    Temple MD; Murray V
    Int J Biochem Cell Biol; 2005 Mar; 37(3):665-78. PubMed ID: 15618023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of cisplatin 1,2-intrastrand guanine-guanine DNA adducts in human leukocytes by high-performance liquid chromatography coupled to inductively coupled plasma mass spectrometry.
    Harrington CF; Le Pla RC; Jones GD; Thomas AL; Farmer PB
    Chem Res Toxicol; 2010 Aug; 23(8):1313-21. PubMed ID: 20666396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction of DNA-targeted platinum phenanthridinium complexes with DNA.
    Whittaker J; McFadyen WD; Wickham G; Wakelin LP; Murray V
    Nucleic Acids Res; 1998 Sep; 26(17):3933-9. PubMed ID: 9705500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins.
    Ohndorf UM; Rould MA; He Q; Pabo CO; Lippard SJ
    Nature; 1999 Jun; 399(6737):708-12. PubMed ID: 10385126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure and functional analysis of the human STAT3 gene promoter: alteration of chromatin structure as a possible mechanism for the upregulation in cisplatin-resistant cells.
    Kato K; Nomoto M; Izumi H; Ise T; Nakano S; Niho Y; Kohno K
    Biochim Biophys Acta; 2000 Sep; 1493(1-2):91-100. PubMed ID: 10978511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.